期刊文献+

显性负突变hTERT在TSA诱导Hela细胞凋亡中的作用

Effect of dominant negative human telomerase reverse transcriptase on apoptosis of Hela induced by trichostatin A
下载PDF
导出
摘要 目的通过转染显性负突变hTERT探讨其在TSA诱导宫颈癌细胞株Hela凋亡中的作用。方法PCR-TRAP-ELISA法检测转染显性负突变,野生型hTERT和对照质粒以后Hela细胞的端粒酶活性。磺酰罗丹明B(sulforhodamine B,SRB)法检测细胞生长率;AnnexinⅤ/PI法检测各组转染细胞在TSA作用下的早期凋亡。结果转染显性负突变hTERT的Hela细胞的端粒酶活性显著低于对照组,2μmol/LTSA作用对照细胞Hela-puro、Hela-DNhTERT和Hela-WThTERT细胞,Hela-DNhTERT相对于Hela-puro生长率差异明显,Hela-DNhTERT细胞凋亡率明显高于Hela-WThTERT和Hela-puro组。结论转染DNhTERT对TSA诱导的Hela细胞凋亡具有协同作用。 [Objiective] This study was designed to investigate effect of dominant negative human telomerase reverse transeriptase on apoptosis of Hela induced by trichostatin A, [Methods] the telomerase activity was detected by PCR and telomeric repeat amplification protocol assay (PCR-TRAP-ELISA). Sulforhodamine B method was employed to determine the growth rate of Hela cells at different time. The early apoptosis was measured by Annexin V/ PI stain and flow cytometry, [Results] After transfected the dominant negative, wild type hTERT and control plasmid into Hela cells, the significant difference of telomeras activity of Hela cells was observed by PCR-TRAP-ELISA assay. DN-hTERT transfected HeLa cells with less telomeras activity were more susceptible to apoptosis induced by trichostatin A. [Conclusion] DN-hTERT transfection might have co-effection on apoptosis of Hela cells induced by trichostatin A.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2008年第1期72-75,共4页 China Journal of Modern Medicine
基金 国家自然科学基金(No:30371657) 国家重大基础研究项目(973)(No:2002CB513107)
关键词 曲古抑菌素A 增殖 凋亡 端粒酶逆转录酶 trichostatin A apoptosis proliferation human telomerase reverse transcriptase
  • 相关文献

参考文献11

  • 1PIER PP. Transcription therapy for cancer[J]. Oncogene, 2001, 20: 3116-3127.
  • 2WEIDLE UH, GROSSMANN A. Inhibition of histone deacetylases: a new strategy, to target epigenetic modifications for anticancer Lreatment[J]. Anticancer Res, 2000, 20: 1471-1486.
  • 3YATABE N, KYO S, KONDO S, et al. antisense therapy directed against human telomerase RNA inhibits telomerase activity ,and induces apoptosis without telomere impairment in cervical cancer cells[J]. Cancer Gene Ther, 2002, 9(7): 624-630.
  • 4KRAEMER K, FUESSEL S, SCHMIDT U, et al. Antisense-mediatd hTERT inhibition specifically reduces the growth of human Bladder cancer cells[J]. Clin Can Res, 2003, 9: 3794-3800.
  • 5TENG L, SPECHT M, BARDEN C, et al. Antisense hTERT inhibits thyroid cancer growth [J]. Clin Endo Meta, 2003, 88: 1362-1366.
  • 6KOSCIOLEK BA, KALANTIDIS K, TABLER M, et al. Inhibition of telomerase activity in human cancer cells by RNA interference [J]. Mol. Can Ther, 2003, 2: 209-216.
  • 7何剑,陈琼,易红.端粒酶的义寡核苷酸抑制肺癌细胞端粒酶活性的研究(英文)[J].中国现代医学杂志,2004,14(11):14-17. 被引量:5
  • 8HAHN WC, STEWART SA, BROOKS MW, et al. Inhibition of telomerase limits the growth of human cancer cells[J]. Nat. Med. 1999, 5: 1164-1170.
  • 9MISAWA M, TAUCHI T, SASHIDA G, et al. Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells[J]. Int. J. Oncol, 2002, 21: 1087-1092.
  • 10ZHANG Y, CAO EH, LIANG XQ, et al. Increasing sensitivity to arsenic trioxide-induced apoptosis by altered telomere state[J]. Eur. J. Pharmacol, 2003, 474: 141-147.

二级参考文献10

  • 1[1]Greider CW.Blackbum EH.Telomerase biochemistry and regulation in cellular immortalization [J].Proc Am Assoc Cancer Res,1995,36:672.
  • 2[2]Hiyama K,Hiyama E,lshioka S.et al.Telomerase activity in small-cell and non-small-cell lung canaers[J].J.Natl.Cancer Inst,1995.87:895-902.
  • 3[3]Kim NW,Piatyszek MA,Prowse KR,et al.Specific association of human telomerase activity with immortal cells and cancers[J].Science,1994,266:2011-2015.
  • 4[4]Shay JW,Gazdar AE.Telomerase in the early detection of cancers[J].J Clin Pathol,1997,50:106-109.
  • 5[5]Hiyama T,Yokozaki H,Kitadai Y,et al.Analysis of expression of human telomerase RNA in gastric precancerous and cancerous by using in mRNA hybridization[J].Nippon Rinsho,1998,56:1190-1193.
  • 6[6]Takamura M,Kyo S,Kanaya R,et al.Expression of human telomerase activity in cervical cancer[J].Cancer Res,1998,58:1559-1561.
  • 7[7]FENG J,Funk WD,WANG SS,et al.The RNA component of human telomeraseIJ].Science,1995,269:1236-1241.
  • 8[8]Mata JE.Joshi SS,Pallen B,et al.A hexameric phosphorothioate oligo-nucleotide telomerase inhibitor arrests growth of Burkitt's lymophoma cells in vitro and vivo [J].Toxicol Appl Phanmacol,1997,144(1):189-197.
  • 9[9]Norton JC,Piatyszek MA,Wright WE,et al.Inhibition of human telomerase activity by peptide nucleic acids [J].Nat Biotechnol,1996,14:615-619.
  • 10[10]Herbert B,Pitts AE.Baker SE,et al.Inhibition of human telomerase inimmortal human cells leads to progressive telomere shortening and cell death [J].Proc Natl Acad Sci USA,1999,96(25):14276-14281.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部